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Immunoglobulin G (IgG) antibodies confer protection
against pathogenic microorganisms, serve as thera-
peutics in tumor therapy, and are involved in destruc-
tion of healthy tissues during autoimmune diseases.
Understanding the molecular pathways and effector
cell types involved in antibody-mediated effector
functions is a prerequisite to modulate these activi-
ties. In this study we used two independent model
systems to identify innate immune effector cells
required for IgG activity in vivo. We first defined the
precise repertoire of receptors for the IgG Fc frag-
ment (FcgR) on innate immune effector cells in the
blood and on tissue-resident macrophage pop-
ulations. Despite expression of relevant activating
FcgRs on various phagocyte populations, our data
indicate that the majority of these cell types are
dispensable for IgG activity in vivo. In contrast,
IgG-dependent effector functions were selectively
impaired in animals lacking the CX3CR1
hiLy6Clo
CD11cint monocyte subset, which expressed the
full set of FcgRs required for IgG activity.
INTRODUCTION
Antibodies of the immunoglobulin G (IgG) subclass are of major
importance for the control of bacterial and viral infections, the
killing of tumor cells during antibody therapy, and the destruction
of healthy tissues during autoimmune diseases such as systemic
lupus erythematosus (SLE), autoimmune haemolytic anemia
(AIHA), autoimmune thrombocytopenia (ITP), and rheumatoid
arthritis (Hogarth, 2002; Nimmerjahn and Ravetch, 2008; Takai,
2002). Despite the capacity of IgG to activate both the classical
complement pathway and effector cells carrying receptors
specific for the IgG Fc fragment (Fcg receptors, FcgRs), studies
of many laboratories suggest that FcgRs are responsible
for mediating IgG effector functions in vivo (Nimmerjahn and
Ravetch, 2008; Ravetch and Clynes, 1998; Takai, 2002). Thus,932 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.mice deficient in the common FcRg chain, essential for cell
surface expression and signaling of all activating FcgRs, or
mice deficient in individual activating FcgRs are resistant to the
development of disease pathology in active and passive models
of autoimmune disease and for the activity of therapeutic anti-
bodies in models of IgG-dependent target cell depletion (Hazen-
bos et al., 1996; Ioan-Facsinay et al., 2002; Kaneko et al., 2006;
Meyer et al., 1998; Nimmerjahn et al., 2005; Nimmerjahn and
Ravetch, 2005, 2008; Takai, 2002; Takai et al., 1994; Uchida
et al., 2004). The family of FcgRs consists of three activating
(FcgRI, FcgRIII, FcgRIV) and one inhibitory (FcgRIIB) member
in mice and a set of orthologous proteins in nonhuman primates
and humans (Hirano et al., 2007; Nimmerjahn and Ravetch,
2006). Coexpression of activating and inhibitory FcgRs sets
a threshold for innate immune effector cell activation and regu-
lates the strength of the initiated responses such as antibody-
dependent cellular cytotoxicity (ADCC), phagocytosis of immune
complexes, and release of proinflammatory mediators. Several
studies have investigated which activating FcgRs are involved
in mediating the activity of the different IgG subclasses. The
picture emerging from this set of data is that the activity of
IgG1 is solely dependent on activating FcgRIII, whereas the
effector functions triggered by the most potent IgG subclasses
IgG2a or c and IgG2b are largely dependent on FcgRIV or combi-
nations of FcgRI and FcgRIV or FcgRIII and FcgRIV (Baudino
et al., 2008; Fossati-Jimack et al., 2000; Giorgini et al., 2008;
Hamaguchi et al., 2006; Hazenbos et al., 1996; Meyer et al.,
1998; Nimmerjahn and Ravetch, 2005; Syed et al., 2009).
Depending on the model system, a contribution of the high-
affinity FcgRI to IgG2a or c activity is observed (Bevaart et al.,
2006; Ioan-Facsinay et al., 2002; Otten et al., 2008). Confirming
the importance of the low-affinity FcgRs for human IgG activity
in vivo, several studies with patient cohorts receiving anti-
tumor antibodies found that patients with high-affinity alleles of
FcgRIIA and FcgRIIIA respond better to therapy (Cartron et al.,
2002; Weng et al., 2004; Weng and Levy, 2003). Despite this
wealth of information about the role of individual FcgRs for IgG
activity, it remains unclear which effector cells are responsible
for these effector functions because most of the potential candi-
date cell populations, such as monocytes, macrophages, and
neutrophils, express an overlapping repertoire of FcgRs (Nim-
merjahn and Ravetch, 2008). Complicating the situation, there
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blood and peripheral tissues such as lung, liver, and spleen
with an unknown FcgR expression pattern that might participate
in these effector functions (Geissmann et al., 2010; Gordon and
Taylor, 2005; Nimmerjahn and Ravetch, 2008). Thus, we set out
to define the FcgRexpression pattern on these different cell pop-
ulations and to identify which of them could be involved in IgG-
mediated platelet phagocytosis as a model system to study
the activity of an autoantibody and IgG-dependent B cell deple-
tion, as a model for therapeutic IgG applications in vivo. This
analysis revealed that only select monocyte and macrophage
populations expressed the relevant set of receptors previously
identified to be important for IgG subclass activity (Baudino
et al., 2008; Giorgini et al., 2008; Hamaguchi et al., 2006; Hirano
et al., 2007; Nimmerjahn et al., 2005; Nimmerjahn and Ravetch,
2005; Syed et al., 2009). By using a variety of genetically ablated
mouse strains and target cell depletion approaches, we have
shown that the CX3CR1
hiLy6Clo monocyte subset (also referred
to as nonclassical or resident subset) expresses the relevant set
of activating and inhibitory FcgRs and is critically involved in
IgG-dependent effector functions in vivo.
RESULTS
FcgR Expression Pattern on Monocyte and Macrophage
Cell Populations
Given the important role of selective FcgRs for IgG-mediated
effector functions, we reasoned that identification of the FcgR
expression repertoire on innate immune effector cells might
provide an insight into responsible effector cell populations.
Most importantly, the precise expression pattern of mouse acti-
vating FcgRIV, which is essential for IgG2a- and IgG2b-medi-
ated effector functions in a wide variety of in vivomodel systems,
has not been determined in detail so far (Baudino et al., 2008;
Giorgini et al., 2008; Hamaguchi et al., 2006; Nimmerjahn
et al., 2005, 2010; Nimmerjahn and Ravetch, 2005, 2006; Otten
et al., 2008; Syed et al., 2009). An initial characterization of the
expression pattern of FcgRIV demonstrated that blood mononu-
clear cells, neutrophils, and ex-vivo-generated bone-marrow-
derived monocytes and thioglycolate-elicited macrophages did
express FcgRIV (Hirano et al., 2007; Nimmerjahn et al., 2005).
It remained unclear, however, on which tissue-resident macro-
phages and monocyte subsets in the blood, bone marrow, and
spleen this receptor was expressed and how the expression dif-
fered between these cells. Based on the expression of cell
surface markers including the chemokine receptors CX3CR1,
CCR2, and accompanying markers CD11c and Ly6C (Gr-1),
monocytes can be distinguished into two major subsets (Geiss-
mann et al., 2010; Gordon and Taylor, 2005; Ziegler-Heitbrock
et al., 2010). The Ly6ChiCX3CR1
loCD11cCCR2hi subset (also
called inflammatory or classical monocytes) has been shown
to be recruited to tissues during inflammation (Geissmann
et al., 2003; Serbina and Pamer, 2006). The Ly6CloCX3CR1
hi
CD11cintCCR2lo subset (also called resident or nonclassical
monocytes) has been initially hypothesized to be important for
maintaining the repertoire of tissue macrophages during the
steady state, but recent data tend to indicate that they are local-
ized mainly at the endothelium where these cells may have
a gatekeeper function (Auffray et al., 2007; Cros et al., 2010;IGeissmann et al., 2010; Ziegler-Heitbrock et al., 2010). As shown
in Figure 1A, FcgRIV expression was restricted to the Ly6Clo
monocyte subset in the blood, spleen, and bone marrow, identi-
fying this activating FcgR as a marker for this monocyte popula-
tion. A recent study has identified this monocyte subset to be
expanded in the autoimmune BXSB mouse strain, suggesting
a role for this cell type in autoimmune inflammation (Santiago-
Raber et al., 2009, 2011). In general, Ly6Clo monocytes ex-
pressed the broadest range of FcgRs including all activating
FcgRs and the inhibitory FcgRIIB. As shown before, the only
other cell type expressing FcgRIV were neutrophils, although
at a lower amount. In contrast to this rather selective expression
pattern of FcgRIV, FcgRIII and FcgRIIB were broadly expressed,
although the amount of expression differed between cell types
(Figure 1A). On tissue macrophages, FcgRIV was detectable
on red pulp macrophages in the spleen and on Kupffer cells in
the liver (Figure 1B). Together with previous data demonstrating
FcgRIV expression on alveolar macrophages, these results
suggest that this activating FcgR is expressed on tissue-resident
macrophages and the Ly6Clo monocyte subset (Mancardi et al.,
2008; Syed et al., 2009).
Involvement of Tissue-Resident Macrophages in ITP
In chronic human ITP, removal of the spleen can stabilize platelet
counts in about 60%–70% of patients, which has been used as
indirect evidence that splenic-resident macrophages might be
involved in autoantibody-mediated platelet phagocytosis (Bib-
urger et al., 2010; Cines and McMillan, 2005; Mizutani et al.,
1992). Moreover, liver-resident macrophages (Kupffer cells) are
suggested to be involved in removal of opsonized platelets and
do express the relevant activating FcgRIV (Figure 1B; Coetzee
et al., 2000; Heyns et al., 1980; Schmidt and Rasmussen,
1985; Stratton et al., 1989). To analyze whether autoantibody
deposits in the spleen and liver, we labeled the anti-platelet anti-
body 6A6-IgG2a and an isotype control antibody with quantum
dots that can be identified by fluorescent microscopy in tissue
sections after antibody injection. Indeed, the autoantibody but
not the isotype control could be identified in the red pulp of the
spleen and in the liver (Figures 2A and 2C). To investigate
whether the spleen is required for IgG-mediated platelet deple-
tion, we splenectomized mice and investigated the capacity of
two 6A6 subclass switch variants to deplete platelets in these
animals. Surprisingly, neither of the two IgG subclasses was
impaired in its activity in vivo, suggesting that splenic-resident
phagocytic cell populations were not required for platelet
depletion in this acute model system in vivo (Figure 2B). Further
analysis of liver tissue sections showed that the deposited auto-
antibodies were not localized close to F4/80-positive Kupffer
cells but rather in proximity to endothelial cells (Figures 2C
and 2D). Because endothelial cells in the liver selectively ex-
pressed the inhibitory FcgRIIB (Figure S1 available online), they
may not contribute to platelet removal according to previous
studies obtained in FcgRIIB-deficient mice, showing that the
inhibitory Fc receptor is a negative regulator of platelet depletion
rather than contributing to platelet phagocytosis (Nimmerjahn
and Ravetch, 2005). Consistently, depletion of liver-resident
macrophages by clodronate liposomes did not impair auto-
antibody deposition (Figure 2D). The importance of hematopoi-
etic cells in IgG-mediated platelet phagocytosis was furthermmunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc. 933
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Figure 1. FcgR Expression Pattern on Innate Immune Effector Cells
(A) The relative expression of all activating FcgRs (FcgRI, FcgRIII, FcgRIV) and the inhibitory FcgRIIB was determined on a variety of innate immune effector cells
including neutrophils, eosinophils, the Ly6Clo and the Ly6Chi monocyte subsets, and lymphocytes in peripheral blood, bone marrow, and spleen. Shown is the
increase in the median fluorescence intensity (DMFI) caused by the respective fluorochrome-labeled FcgR-specific antibodies.
(B) Identification of FcgRIV expression on tissue-resident macrophages in the spleen and the liver. Macrophages were identified by staining with F4/80, and
FcgRIV expression was identifiedwith themonoclonal antibody 9E9. The scale bars represent 100 mm. Shown are representative pictures from three independent
experiments.
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Ly6Clo Monocytes and IgG Effector Functionsconfirmed by using bone marrow chimeras. As shown in Fig-
ure 2E, platelet phagocytosis was restored if common FcRg
chain-deficient mice (Fcer1g/), which are resistant to IgG
subclass-dependent platelet depletion, were reconstituted with
bone marrow of wild-type mice. Conversely, no platelet deple-
tion was observed in wild-type mice reconstituted with bone
marrow of g chain-deficient animals. To investigate whether
recruitment of neutrophils to peripheral tissues was important
for platelet removal, we induced platelet depletion in CD11b-934 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.deficient animals. Despite the absence of CD11b, IgG-mediated
platelet depletion was not impaired (Figure 2F). Similar results
were obtained in CX3CR1-deficient mice as shown in Figure 2G.
Mast Cells, Basophils, Eosinophils, and Neutrophils Are
Not Required for IgG-Dependent Platelet Depletion
Mast cells are essential for the initiation of many IgG-dependent
proinflammatory reactions, and the absence of mast cells abro-
gates the induction of joint inflammation in a model of serum
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Figure 2. Involvement of Spleen- and Liver-Resident Phagocytes in Autoantibody Activity
(A) Deposition of the quantum dot (Qdot)-labeled platelet-specific antibody 6A6-IgG2a or an isotype control antibody in the spleen 20 min after intravenous
injection. Endothelial cells were identified by staining with aCD31-specific antibody and neutrophils were identified by staining with a Ly6G-specific antibody. The
inset shows a selected area of CD31 and 6A6-IgG2a-Qdot staining.
(B) Shown is the platelet-depleting activity of the 6A6-IgG1 and 6A6-IgG2a platelet-specific antibodies in C57BL/6 mice either left untreated (n = 5) or
splenectomized (n = 3).
(C) Deposition of the quantumdot (Qdot)-labeled platelet-specific antibody 6A6-IgG2a or an isotype control antibody in the liver 20min after intravenous injection.
As before, CD31 was used as an endothelial marker and F4/80 as a marker for liver-resident macrophages.
(D) Deposition of quantum dot (Qdot)-labeled 6A6-IgG2a in the liver of PBS or clodronate liposome-pretreated mice at the indicated time points after intravenous
injection. Tissue-resident macrophages were identified by staining with an F4/80-specific antibody. See also Figure S1.
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Ly6Clo Monocytes and IgG Effector Functionstransfer arthritis and impairs the Arthus reaction (Lee et al., 2002;
Nigrovic et al., 2007). To investigate whether mast cells or mast
cell-derived cytokines are involved in IgG-dependent platelet
depletion, we induced ITP in mast cell-deficient Kit/ mice or
in mice lacking the receptors for the proinflammatory cytokines
IL-1 or TNF-a. Compared to wild-type animals, no difference in
the activity of platelet depletion was observed, suggesting that
mast cells were not involved in anti-platelet IgG activity (Fig-
ure 3A). Besides Ly6Clo monocytes, neutrophils do express
FcgRIV and may have the capacity to phagocytose opsonized
material. To specifically deplete neutrophils, we used the
Ly6G-specific antibody 1A8. As shown in Figures 3B and 3C,
injection of this antibody diminished neutrophil numbers by
more than 90%, without affecting other cell populations. Despite
the absence of neutrophils, however, IgG-dependent platelet
depletion was not affected compared to mock-treated animals
(Figure 3D). Similar results were obtained in mice deficient for
the transcription factor GATA1, which lack eosinophils as well
as after depletion of basophils with an FcεRI-specific antibody
(Figures 3E–3G). Thus, this set of experiments suggests that
neither mast cells, basophils, eosinophils, nor neutrophils are
involved in platelet removal.
Involvement of Monocyte Subpopulations in IgG Activity
In Vivo
To identify cells that could bind the autoantibody, we injected
into mice fluorescently labeled normal or mutated anti-platelet
antibodies deficient in FcgR binding because of absent IgG
heavy chain glycosylation (N297A). Analysis of autoantibody
binding to different cell populations expressing FcgRs 20 min
after injection showed binding to both Ly6Chi and Ly6Clo mono-
cyte populations in the blood with only minor binding to other
innate immune effector cells including neutrophils (Figures 4A
and 4B). Depletion of both monocyte subsets (and all tissue-
resident macrophages) resulted in a block of autoantibody
activity indicating that either or both of these monocyte subsets
are crucial for IgG activity (Figures S2A–S2C). To distinguish
between the contribution of the Ly6Clo and the Ly6Chi monocyte
subset for IgG activity, we specifically depleted the latter sub-
population with the CCR2 chemokine receptor-specific antibody
MC-21. As shown in Figures 4C and 4D, injection of this antibody
resulted in an efficient and highly specific removal of Ly6Chi
monocytes without a major impact on the Ly6Clo monocyte pop-
ulation, neutrophils, and eosinophils. Despite the absence of
these cells, the efficiency of IgG-dependent platelet depletion re-
mained unchanged, arguing against a major involvement of
these cells (Figures 4E and 4F). To achieve a selective depletion
of the FcgRIV-positive Ly6Clo monocyte subset, we titrated the
amount of clodronate liposomes down to a single injection of
10 ml 2 hr before autoantibody injection. At this dose, the number
of Ly6Clo monocytes was reduced to about 15%–20%of its orig-
inal number, whereas neither tissue-resident macrophages in
the liver nor Ly6Chi monocytes and neutrophils were affectedThe scale bars represent 50 mm.
(E) Platelet-depleting activity of the 6A6-IgG2a antibody in C57BL/6 (n = 5), Fcer1g
C57BL/6 mice transplanted with bone marrow of Fcer1g/ (n = 3) animals.
(F and G) Shown are the relative platelet counts 4 hr after injection of the 6A6-
(Cx3cr1GFP/GFP) (n = 4) animals. *p < 0.05.
936 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.by the treatment (Figures 5A–5C). This selective reduction of
Ly6Clo monocytes translated into impaired autoantibody activity
(Figure 5D). Similar results were obtained in Cd11c-DTR mice,
which express the simian diphtheria toxin receptor under the
control of the Cd11c promoter (Jung et al., 2002). Besides den-
dritic cells, CD11c is selectively expressed on the Ly6Clo but not
on the Ly6Chi monocyte subset or on tissue-resident macro-
phages of the liver and spleen (Hashimoto et al., 2011). Indeed,
injection of diphtheria toxin resulted in a reduction of Ly6Clo
blood monocytes but did not deplete liver-resident Kupffer cells
or splenic red pulp macrophages as shown before (Figures
S3A–S3C; Jung et al., 2002; Probst et al., 2005). Consistent
with the results of the clodronate experiment, this translated
into reduced autoantibody activity (Figure 5E). Further support-
ing these data, mice deficient in FcgRI and FcgRIVwere resistant
to IgG2a-dependent platelet depletion (Figure 5F). As shown in
Figure 1A, this combination of activating FcgRs is selectively
expressed on Ly6Clo monocytes in the blood. Moreover, when
plotting the cell numbers of neutrophils and Ly6Chi and Ly6Clo
monocytes of all our previous experiments against the platelet-
depleting activity of the autoantibody, a clear correlation
between IgG activity and cell number could be seen only for
Ly6Clo monocytes (Figure S3D).
Previous studies have shown that both monocyte subsets can
phagocytose particulate matter (Nahrendorf et al., 2007; Panizzi
et al., 2010; Tacke et al., 2006). To study the endocytic and
phagocytic activity of bothmonocyte subsets in the blood during
the steady state, we first injected liposomes containing the fluo-
rescent dye PKH26, which can be detected by flow cytometric
analysis upon uptake into cells. As shown in Figures 6A–6C,
Ly6Clo monocytes in the blood had the highest capacity to
acquire the labeled liposomes by fluid phase endocytosis. In
contrast, the same monocyte population was less active in lipo-
some uptake in the bone marrow (Figure S4). To address the
capacity to phagocytose particulate matter, mice were injected
with fluorescently labeled beads. Under these conditions, both
Ly6Chi and Ly6Clo monocyte subsets were able to phagocytose
the beads although the latter showed a trend toward a higher
phagocytic activity during the first 2 hr, consistent with previous
reports (Figure 6D; Tacke et al., 2006).
Role of Ly6Clo Monocytes for IgG-Dependent B Cell
Depletion
To establish a broader role of the Ly6Clo monocytes for IgG
activity, we used an IgG2a antibody recognizing mouse CD20
to deplete B cells. As shown for other IgG2a antibodies, B cell
depletion by this antibody occurred in an Fcg-dependentmanner
(Figures 7A, 7B, and S5; Hamaguchi et al., 2006). Consistent with
our results in the platelet depletion model, B cell depletion
in the blood was not affected by the absence of splenic-resident
monocytes and macrophages, neutrophils, or the Ly6Chi mono-
cyte subset (Figures 7C–7E). In contrast, selective depletion
of Ly6Clo monocytes by injection of low-dose clodronate/ (n = 5), Fcer1g/mice transplanted with C57BL/6 bonemarrow (n = 3) and
IgG2a antibody in CD11b-deficient (Cd11b/) (n = 4) and CX3CR1-deficient
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Figure 3. Involvement of Mast Cells, Neutrophils, Basophils, and Eosinophils in Autoantibody-Dependent Platelet Depletion
(A) Shown is the residual platelet count 4 hr after injection of the 6A6-IgG2a antibody in the indicated mouse strains.
(B) Flow cytometric analysis of cell populations in the peripheral blood of PBS-treated mice or animals injected with the neutrophil-specific antibody 1A8. Natural
killer (NK) cells and Ly6Clo and Ly6Chi monocytes were identified by low side scatter and by staining with CD62L, CD11b, and NK1.1 (not shown) (left). Neutrophils
(Neu) and eosinophils (Eo) were identified by high expression of CD11b, Gr-1, and high side scatter (SSC) (right).
(C) Numbers of Ly6Clo and Ly6Chi monocytes, neutrophils, and eosinophils in the peripheral blood of PBS- or 1A8-treated animals 36 hr after neutrophil
depletion (n = 3).
(D) Shown is the platelet count 4 hr after injection of the 6A6-IgG2a antibody in mice pretreated with PBS (n = 3) or 1A8 to deplete neutrophils (n = 3).
(E) Gata1/ mice lacking eosinophils were injected with 6A6-IgG2a and platelet counts were determined before and 4 hr after antibody injection.
(F) Shown are the basophil counts in the peripheral blood of mice 24 hr after injection of the FcεRI-specific MAR-1 antibody.
(G) Platelet counts in the peripheral blood of mice that were depleted of basophils before (0 hr) and 4 hr after induction of ITP by injection of 6A6-IgG2a.
*p < 0.05.
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Ly6Clo Monocytes and IgG Effector Functionsliposomes or deletion of FcgRI and FcgRIV selectively coex-
pressed on this monocyte subset efficiently interfered with B
cell depletion (Figures 7F and7G). To directly assess the capacityIof the two monocyte subsets and neutrophils to kill B cells via
antibody-dependent cellular cytotoxicity (ADCC), we isolated
these different cells from the peripheral blood by cell sortingmmunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc. 937
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Figure 4. Involvement of Ly6Chi Monocytes in Autoantibody-Mediated Platelet Depletion
(A and B) Binding of the fluorescently labeled platelet-specific antibodies 6A6-IgG2a (A) and 6A6-IgG1 (B) to the indicated cell populations in the blood 20 min
after injection. Aglycosylated antibody variants deficient in FcgR binding (N297A) served as controls. One out of three representative experiments is shown.
(C) Flow cytometric analysis of cell populations in the peripheral blood after injection of an isotype control antibody or the MC21 antibody recognizing CCR2 on
Ly6Chi monocytes. Natural killer (NK) cells, Ly6Clo monocytes, and Ly6Chi monocytes were identified by low side scatter and by staining with CD62L, NK1.1, and
CD11b (left). Neutrophils (Neu) and eosinophils (Eo) were identified by high expression of CD11b, high side scatter (SSC), and the presence (Neu) or absence (Eo)
of Gr-1 and FcgRIV (right).
(D) Quantification of neutrophils, eosinophils, and Ly6Clo and Ly6Chi monocyte subsets after injection of MC21 or an isotype-matched control antibody.
(E and F) Shown is the platelet count before and 4 hr after injection of the 6A6-IgG1 (E) and 6A6-IgG2a (F) antibodies in mice pretreated with MC21 (n = 3) or the
isotype control (n = 3).
See also Figure S2.
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Ly6Clo Monocytes and IgG Effector Functionsand performed ADCC assays with sorted B cells in vitro. As de-
picted in Figure 7H, Ly6Clo monocytes had the greatest capacity
to kill B cells, suggesting that this monocyte subset may be of
general importance for IgG-dependent effector functions in vivo.938 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.DISCUSSION
It is generally accepted that cellular FcgRs are crucial for
IgG-dependent effector functions including phagocytosis,
A B C
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μl)
Figure 5. Involvement of Ly6Clo Monocytes
in Autoantibody-Mediated Platelet Deple-
tion
(A) Quantification of cell numbers of Ly6Chi and
Ly6Clo monocytes in mice that were either left
untreated or injected with PBS or with 10 ml
of clodronate liposomes to deplete the Ly6Clo
monocyte subset.
(B) Shown are liver sections stained with an F4/80
antibody specific for liver-resident macrophages
2 hr after injection of 10 ml clodronate liposomes
or PBS.
(C) Blood neutrophil counts in mice left either
untreated or injected with PBS or 10 ml of clodro-
nate liposomes 2 hr after injection.
(D) Platelet depletion activity of the 6A6-IgG2a
antibody in mice either left untreated or pretreated
with PBS or clodronate liposomes 2 hr before
antibody injection.
(E) Platelet-depleting activity of the 6A6-IgG2a
antibody in the indicated mouse strains 24 hr
after pretreatment with diphtheria toxin (+DT) or
PBS (DT).
(F) Residual platelet count in C57BL/6 and
Fcgr1/Fcgr4/ mice 4 hr after injection of the
6A6-IgG2a anti-platelet antibody.
*p < 0.05. See also Figure S3.
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Ly6Clo Monocytes and IgG Effector Functionsantibody-dependent cell-mediated cytotoxicity (ADCC), and the
release of a variety of cytokines, chemokines, and cytotoxic
substances (Nimmerjahn and Ravetch, 2008; Takai, 2002).
Because the members of this receptor family are widely ex-
pressed on cells of the innate immune system and especially
on phagocytic lineages such as monocytes, macrophages,
and neutrophils, the identification of cell populations partici-
pating in these IgG-dependent activities is demanding. Under
conditions of acute or chronic inflammation, different cell types
become recruited to sites of inflammation, making it difficult to
delineate which of the individual cell types are important for anti-
body-dependent effects. Therefore, we chose platelet- and B
cell-depletion model systems with a fast kinetic excluding the
need for inflammation- and cytokine-dependent recruitment of
cells to sites of IgG activity. This short assay time enabled us
to use a variety of transient target cell-depletion strategies that
are difficult to use in models that require more time for the
readout and the consecutive recruitment of different cell types.
A similar kinetic of antibody-mediated platelet or B cell depletion
can be observed in healthy human volunteers injected with
serum from patients with ITP (Sprague et al., 1952) or in tumor
patients treated with B cell-depleting antibodies such as Rituxi-
mab. Starting from our previous studies that identified FcgRIV as
one of the important activating Fcg receptors for IgG2a activity in
the twomodel systems, we now performed a detailed analysis of
the cellular distribution of all Fcg receptors (Hamaguchi et al.,
2006; Nimmerjahn et al., 2005, 2007; Nimmerjahn and Ravetch,
2005). These experiments showed that FcgRIV is selectively ex-
pressed on the Ly6CloCD11cint monocyte subset, at a lowerImmunity 35, 932–944, Damount on neutrophils and on tissue-resi-
dent macrophages. Based on sequence
similarity, FcgRIVmay be the orthologousreceptor to human FcgRIIIA, because the expression pattern on
Ly6Clo monocytes is consistent with the corresponding nonclas-
sical or resident monocyte subset in humans (Gordon and
Taylor, 2005; Nimmerjahn et al., 2005; Ziegler-Heitbrock et al.,
2010). The importance of FcgRIIIA for human ITP is shown by
the efficient inhibition of platelet depletion in patients and in
transgenic mice after infusion of blocking antibodies for this re-
ceptor (Clarkson et al., 1986; Samuelsson et al., 2001). With
respect to B cell depletion, several studies indicate that patients
carrying FcgRIIIA alleles with increased affinity for human IgG1
show better therapeutic outcomes (Cartron et al., 2002; Weng
et al., 2004; Weng and Levy, 2003).
Our data, acquired by a variety of pharmacological, sur-
gical, and genetic approaches, suggest that the FcgRIV+
CD11cintLy6Clo monocyte subset in the blood may be important
for IgG-dependent platelet removal and B cell depletion in vivo.
However, previous studies suggest that tissue-resident phago-
cyte populations of the spleen and liver might be involved in
autoantibody-mediated platelet depletion, and removal of the
spleen is an effective treatment in humans with a therapeutic
success rate of 60%–70% (Bussel, 2006; Cines and McMillan,
2005; Heyns et al., 1980; Mizutani et al., 1992; Schmidt and Ras-
mussen, 1985; Stratton et al., 1989). There are several possible
explanations for these contradictory results. The most apparent
one is that the model system used in this study is an acute and
only transient model with a fast recovery of platelet numbers.
In ITP patients, autoantibodies are produced constantly by
plasma cells, which might result in the recruitment of additional
cell types of the mononuclear phagocyte system. Moreover,ecember 23, 2011 ª2011 Elsevier Inc. 939
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Figure 6. Endocytic and Phagocytic Activity of
Monocyte Subsets
(A) Shown is the uptake of fluorescently labeled (PKH26)
liposomes by Ly6Clo and Ly6Chi monocyte subsets of the
peripheral blood before (0 min) and 20 min after intrave-
nous injection.
(B) Quantification of PKH26-labeled liposome uptake by
the indicated cell types in the peripheral blood by analysis
of their median fluorescence intensity (MFI) prior and
20 min after injection.
(C) Kinetics of the uptake of PKH26-labeled liposomes by
the indicated cell types in the peripheral blood. See also
Figure S4.
(D) Phagocytosis of fluorescently (flash-red) labeled beads
by Ly6Chi and Ly6Clo monocytes at the indicated time
points after intravenous injection.
Immunity
Ly6Clo Monocytes and IgG Effector Functionsremoval of the spleen might stabilize platelet counts not only
by removing resident phagocytic cell populations but also by
impairing the generation of autoantibodies by plasma blasts or
plasma cells. Moreover, the accumulation of radioactivity in the
spleen and liver observed upon injection of radiolabelled plate-
lets is an indirect readout and does not prove that these sites
are dominant players in IgG-dependent platelet removal. We
also observed an accumulation of autoantibody in spleen and
liver, although it was not required for removing the majority of
platelets from the circulation and occurred in the absence of
organ-resident macrophages. Further evidence arguing against
an involvement of liver-resident Kupffer cells for IgG-mediated
platelet depletion is their lack of FcgRIIB expression, which
has been identified as a negative regulator of IgG (autoantibody
and therapeutic IgG) activity in vivo (Kumar et al., 2006; Nimmer-
jahn and Ravetch, 2005). Formally excluding a role of the liver or
liver-resident cells is challenging, because in contrast to the
spleen it is impossible to remove this organ without affecting
viability. Moreover, it is possible that cell types such as neutro-
phils or classical monocytes might participate in an indirect
cooperative manner in these IgG-mediated effector functions.
With respect to IgG-dependent B cell depletion, our results are
in line with previous reports suggesting that myeloid cells might
be important for ADCC activity in mice. For example, ADCC
reactions mediated by IgG2a antibodies are found to be depen-
dent on activating FcgRIV and are enhanced in mice lacking
FcgRIIB (Hamaguchi et al., 2006; Nimmerjahn et al., 2010; Nim-
merjahn and Ravetch, 2005). By using an Fcgr1/Fcgr4/
mouse, we have shown that both of these receptors are essential
for IgG activity. This FcgR combination is selectively expressed
on Ly6Clo monocytes but not on the Ly6Chi subset, not on neu-
trophils, natural killer (NK) cells, or other innate immune effector
cells in the blood, spleen, and bone marrow of mice. In line with940 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.the in vivo data, sorted Ly6Clo monocytes were
superior to neutrophils or Ly6Chi monocytes in
antibody-dependent killing of B cells in vitro.
Taken together, our experiments demon-
strate that despite widespread expression of
FcgRs on innate immune effector cells, a rather
select subpopulation of monocytes may be
crucial for antibody-mediated platelet phagocy-
tosis and B cell depletion in mice in vivo. In thelight of the recent finding that an FcgRIV-positive monocyte
subset is selectively expanded in lupus-prone mice, it seems
possible that this cell type is centrally involved in mediating
IgG-dependent tissue pathology (Santiago-Raber et al., 2009,
2011). Despite functional overlaps between mouse and human
FcgRs and the respective mouse and humanmonocyte subsets,
there are also important functional differences, necessitating
further studies before definitive conclusions can be drawn for
the human system (Gordon and Taylor, 2005; Ziegler-Heitbrock
et al., 2010).
EXPERIMENTAL PROCEDURES
Mice
Female mice at 8–15 weeks of age on the C57BL/6 background obtained from
Janvier (Le Genest-Saint-Isle, France) were used in all experiments. Kit-
deficient (Kit/), GATA1-deficient (Gata1/), CD11b-deficient (Cd11b/),
interleukin-1-receptor-deficient (Il1r1/), and tumor necrosis factor receptor
a- and b-deficient (Tnfrsf1a/ Tnfrsf1b/) mice were obtained from the Jack-
son Laboratories. FcRg-chain-deficient mice (Fcer1/) were provided by
J. Ravetch. Cx3cr1GFP/GFP and Cd11c-DTR transgenic mice were kindly
provided by D. Littman through Jackson Laboratories. All mice were main-
tained under specific-pathogen-free conditions and according to the guide-
lines of the National Institutes of Health and the legal requirements in Germany
and the USA.
In Vivo Experiments
ITP was induced by intravenous injection of 4 mg of 6A6 IgG subclass
switch variants as described (Nimmerjahn et al., 2005; Nimmerjahn and
Ravetch, 2005). Platelet counts were determined by one of two methods:
(1) blood was diluted in PBS and 5% BSA (1:2 to maximum 1:10 dilution)
and analyzed in an Advia 120 hematology system (Siemens), or (2) blood
was diluted 1:100, stained with anti-CD61-FITC (dilution 1:50–1:100), and
analyzed in a final dilution of 1:1,000 or 1:2,000 by flow cytometry. In the
latter method, platelets were identified by their light scatter characteristics
(determining forward scatter and side scatter on a logarithmic scale)
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Figure 7. Role of Monocyte Subpopulations in IgG-Dependent B Cell Depletion
(A–G) Shown is the percentage of peripheral blood B cells 6 and 24 hr after injection of 100 mg of an CD20-specific IgG2a antibody in C57BL/6mice (A), Fcer1g/
mice (B), splenectomized mice (C), mice depleted of neutrophils (D), Ly6Chi monocytes (E), Ly6Clo monocytes (10 ml clodronate) (F), or in mice deficient for the
activating FcgRs I and IV (Fcgr1/ Fcgr4 /) (G). In all experiments four to five mice per group were used. See also Figure S5.
(H) Shown is the capacity of Ly6Clo monocytes, Ly6Chi monocytes, and neutrophils to mediate antibody-dependent killing of B cells in vitro at the indicated
effector to target cell ratios in the presence of the CD20-specific IgG2a or an isotype control antibody. Shown is one out of three independent experiments.
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Ly6Clo Monocytes and IgG Effector Functionstogether with positive staining for CD61, and their relative numbers per
blood volume were calculated based on the platelet numbers counted in
a defined period at constant flow rates. B cell depletion was induced by
intravenous injection of 100 mg of a CD20-specific antibody generated in
the institute by T. Winkler. B cell counts were determined before and 6 or
24 hr after antibody injection by FACS analysis. B cells counts before anti-
body injection were set to 100%.
In Situ Analysis of Autoantibody Binding
To analyze localization of anti-platelet antibodies in liver or spleen in situ,
purified 6A6-IgG2a was labeled with QDot705 nanochrystals with QDot705
antibody conjugation kit (Invitrogen). To detect binding of 6A6-IgG subclasses
to cell populations by flow cytometry, the antibody was conjugated with
Alexa Fluor 647 with the Alexa Fluor 647 monoclonal antibody labeling kit
(Invitrogen).IDepletion of Innate Immune Effector Cells
For depletion of neutrophils, mice were injected with 0.5 mg of the
Ly6G-specific antibody (clone 1A8; provided by T. Malek via BioXcell) 30 hr
prior to ITP induction as described previously (Daley et al., 2008). For depletion
of Ly6Chi monocytes, mice were injected intraperitoneally with 50 mg of
a CCR2-specific antibody (clone MC-21) the day before ITP induction. Baso-
phil depletion was achieved by two daily injections of 5 mg of the FcεR1-
specific MAR1 antibody 3 consecutive days prior to 6A6-IgG2a injection.
For depletion of phagocytic cell populations, mice were injected with the indi-
cated amounts of liposome-encapsulated dichloromethylene-bisphospho-
nate (clodronate liposomes) 2 hr or 20 hr before ITP induction. Depletion of
CD11c-positive cells in Cd11c-DTR mice was achieved by a single injection
of 4 ng/g diphtheria toxin as described (Jung et al., 2002). The efficiency of
cell depletion was verified by flow cytometry and immunofluorescence
analysis.mmunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc. 941
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Ly6Clo Monocytes and IgG Effector FunctionsFluorescence Labeling of Phagocytic Cell Populations by Liposome
Uptake
PBS liposomes were labeled with the PKH26 cell linker mini kit (Sigma-Aldrich
Chemie GmbH, Munich, Germany). Per staining reaction, 1 ml of PBS lipo-
somes were sedimented by centrifugation (200 3 g, 3 min) and supernatant
was removed. Liposomes were resuspended in 1 ml of diluent C. This suspen-
sion was mixed with an equal volume of diluent C containing PKH26 and the
reaction was incubated for 5 min at room temperature prior to addition of
1ml of fetal calf serum for termination of the reaction. Liposomes were washed
once in PBS with 1% BSA and several times with PBS. Finally, PKH26-labeled
liposomes were resuspended in 600 ml PBS and 150 ml of this suspension was
used for injection.
Bone Marrow Chimeras
For the generation of bone marrow chimeric mice, five million bone marrow
cells from C57BL/6 or Fcer1g/ mice were injected into lethally irradiated
(9 Gy) C57BL/6 or Fcer1g/ recipientmice. Twomonths later, micewere eval-
uated for the presence of donor cells by flow cytometric analysis. For subse-
quent experiments, only mice with a chimerism greater than 95% were used.
Flow Cytometry
Flow cytometric analysis was done on a FACS Canto II (BD Biosciences,
Heidelberg, Germany) with single-cell suspensions of peripheral blood, bone
marrow, and spleen. Unless otherwise indicated, 1 3 105 to 1 3 106 cells
were incubated on ice for at least 10 min with Fc block (clone 2.4G2, 0.5 mg
per sample) to reduce unspecific binding to Fc receptors. When staining for
the individual FcgRs, Fc block was omitted. Analysis was restricted to viable
cells, which were identified by exclusion of nucleic acid binding dye 40,6-
Diamidino-2-phenylindol (DAPI). To exclude cell aggregates from analysis,
we used a gating strategy excluding events with an unproportionally large
area of the forward scatter signal relating to its height. Cell numbers per blood
volumewere calculated based on the respective numbers counted in a defined
period at defined flow rates. Data acquisition and analysis was performed with
the FACS Diva software (BD Biosciences). A complete list of antibodies and
a precise description of the gating strategy used to identify monocyte subpop-
ulations can be found in the Supplemental Information.
Immunohistochemistry
6 mm sections of frozen tissue were air-dried overnight followed by fixation in
acetone. When biotinylated antibodies were used on liver sections, blocking
of endogenous biotin was performed with an Avidin-Biotin blocking kit
(Invitrogen) according to manufacturer’s instructions. The sections were
analyzed with an Axiovert 200M microscope (Carl Zeiss AG, Oberkochen,
Germany) supplied with an AxioCam MRM camera. A complete list of anti-
bodies used for immunohistochemistry can be found in the Supplemental
Information.
In Vitro ADCC Assays
Naive B cells, neutrophils, and Ly6Clo and Ly6Chi monocytes were isolated
from C57BL/6 mice by flow cytometric sorting on a FACS Aria III (BD). Cells
were combined at the indicated effector to target cell ratios in 96-well plates
with the CD20-specific IgG2a antibody or an isotype-matched control anti-
body and incubated for 16–20 hr at 37C before determination of total cell
numbers and flow cytometric analysis to quantify the cell types present in
the culture.
Statistical Analysis
All data are expressed as mean ± standard deviation. Data were analyzed
and plotted with GraphPad Prism software (GraphPad Software Inc., San
Diego, CA). For calculation of statistical significance, data were analyzed
with Student’s t test or, in the case of unequal variances, Student’s t test
with Welch modification. p% 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.immuni.2011.11.009.942 Immunity 35, 932–944, December 23, 2011 ª2011 Elsevier Inc.ACKNOWLEDGMENTS
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